Your browser doesn't support javascript.
loading
A combination of two human neutralizing antibodies prevents SARS-CoV-2 infection in cynomolgus macaques.
Cobb, Ronald R; Nkolola, Joseph; Gilchuk, Pavlo; Chandrashekar, Abishek; Yu, Jingyou; House, Robert V; Earnhart, Christopher G; Dorsey, Nicole M; Hopkins, Svetlana A; Snow, Doris M; Chen, Rita E; VanBlargan, Laura A; Hechenblaickner, Manuel; Hoppe, Brian; Collins, Laura; Tomic, Milan T; Nonet, Genevieve H; Hackett, Kyal; Slaughter, James C; Lewis, Mark G; Andersen, Hanne; Cook, Anthony; Diamond, Michael S; Carnahan, Robert H; Barouch, Dan H; Crowe, James E.
Afiliação
  • Cobb RR; Ology Bioservices, Process Development and Manufacturing, Alachua, FL 32615, USA.
  • Nkolola J; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
  • Gilchuk P; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
  • Chandrashekar A; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
  • Yu J; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
  • House RV; Ology Bioservices, Frederick, MD 21701, USA.
  • Earnhart CG; Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense, US Department of Defense, Frederick, MD 21703, USA.
  • Dorsey NM; Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense, US Department of Defense, Frederick, MD 21703, USA.
  • Hopkins SA; Logistics Management Institute (LMI), Tysons, VA 22102, USA.
  • Snow DM; Ology Bioservices, Frederick, MD 21701, USA.
  • Chen RE; Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.
  • VanBlargan LA; Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
  • Hechenblaickner M; Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.
  • Hoppe B; Ology Bioservices, Process Development and Manufacturing, Alachua, FL 32615, USA.
  • Collins L; Ology Bioservices, Process Development and Manufacturing, Alachua, FL 32615, USA.
  • Tomic MT; Ology Bioservices, Process Development and Manufacturing, Alachua, FL 32615, USA.
  • Nonet GH; Research and Development, Ology Bioservices, Inc., Alameda 94501, CA, USA.
  • Hackett K; Research and Development, Ology Bioservices, Inc., Alameda 94501, CA, USA.
  • Slaughter JC; Ology Bioservices, Frederick, MD 21701, USA.
  • Lewis MG; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
  • Andersen H; Bioqual, Inc., Rockville, MD 20850, USA.
  • Cook A; Bioqual, Inc., Rockville, MD 20850, USA.
  • Diamond MS; Bioqual, Inc., Rockville, MD 20850, USA.
  • Carnahan RH; Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.
  • Barouch DH; Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
  • Crowe JE; Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Med ; 3(3): 188-203.e4, 2022 Mar 11.
Article em En | MEDLINE | ID: mdl-35132398
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article